IBDEI1HS ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24136,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,24136,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,24136,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,24137,0)
 ;;=C44.99^^82^1044^64
 ;;^UTILITY(U,$J,358.3,24137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24137,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,24137,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,24137,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,24138,0)
 ;;=E11.9^^82^1044^16
 ;;^UTILITY(U,$J,358.3,24138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24138,1,3,0)
 ;;=3^DM Type 2
 ;;^UTILITY(U,$J,358.3,24138,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,24138,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,24139,0)
 ;;=E11.40^^82^1044^21
 ;;^UTILITY(U,$J,358.3,24139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24139,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,24139,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,24139,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,24140,0)
 ;;=E78.2^^82^1044^31
 ;;^UTILITY(U,$J,358.3,24140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24140,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,24140,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,24140,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,24141,0)
 ;;=E78.5^^82^1044^32
 ;;^UTILITY(U,$J,358.3,24141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24141,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,24141,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,24141,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,24142,0)
 ;;=E66.3^^82^1044^53
 ;;^UTILITY(U,$J,358.3,24142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24142,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,24142,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,24142,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,24143,0)
 ;;=D64.9^^82^1044^4
 ;;^UTILITY(U,$J,358.3,24143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24143,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,24143,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,24143,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,24144,0)
 ;;=F17.200^^82^1044^50
 ;;^UTILITY(U,$J,358.3,24144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24144,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,24144,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,24144,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,24145,0)
 ;;=F17.229^^82^1044^47
 ;;^UTILITY(U,$J,358.3,24145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24145,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco
 ;;^UTILITY(U,$J,358.3,24145,1,4,0)
 ;;=4^F17.229
 ;;^UTILITY(U,$J,358.3,24145,2)
 ;;=^5003374
 ;;^UTILITY(U,$J,358.3,24146,0)
 ;;=F19.10^^82^1044^67
 ;;^UTILITY(U,$J,358.3,24146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24146,1,3,0)
 ;;=3^Substance Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,24146,1,4,0)
 ;;=4^F19.10
 ;;^UTILITY(U,$J,358.3,24146,2)
 ;;=^5003416
 ;;^UTILITY(U,$J,358.3,24147,0)
 ;;=F15.10^^82^1044^66
 ;;^UTILITY(U,$J,358.3,24147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24147,1,3,0)
 ;;=3^Stimulant Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,24147,1,4,0)
 ;;=4^F15.10
 ;;^UTILITY(U,$J,358.3,24147,2)
 ;;=^5003282
 ;;^UTILITY(U,$J,358.3,24148,0)
 ;;=F43.21^^82^1044^3
 ;;^UTILITY(U,$J,358.3,24148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24148,1,3,0)
 ;;=3^Adjustment d/o w/ Depressed Mood
 ;;^UTILITY(U,$J,358.3,24148,1,4,0)
 ;;=4^F43.21
 ;;^UTILITY(U,$J,358.3,24148,2)
 ;;=^331948
 ;;^UTILITY(U,$J,358.3,24149,0)
 ;;=G43.909^^82^1044^46
